How much does the NHS spend on obesity?

Ready to take the next step? See if you're eligible for expert-led weight loss support.

Check your eligibility

As one of the UK's biggest health challenges, obesity comes at a great cost to the NHS and others. Learn the true cost of obesity in the UK.



As one of the UK's biggest health challenges, obesity comes at a great cost to the NHS and others. Learn the true cost of obesity in the UK.

Obesity is often described as one of the biggest health challenges facing the UK today. The obesity rate has almost doubled since 1993, when it stood at 14.9%. It affects millions and places a huge financial strain on the healthcare system.


With that in mind, how much does the NHS spend on obesity each year? And what is the wider cost to society? Let's find out.


How much money does the NHS spend on treating obesity?

It's estimated that the NHS will spend £9.3 billion on treating obesity-related illnesses in 2025, according to a joint study by Nesta and Frontier Economics. Those health problems include type 2 diabetes, heart disease, high blood pressure and certain types of cancers.


If you add the cost of health problems from being overweight, this figure jumps to an estimated £12.6 billion.


The true cost of obesity

When someone develops health issues linked to obesity, it's not just a question of how much obesity costs the healthcare system. Those costs ripple outwards to other service providers and other corners of society.


Social care costs

People living with obesity are more likely to require some sort of formal social care, whether that's:


  • Carers coming to their house to help them with daily tasks
  • Emotional and mental health support
  • Adaptations to their homes, such as stair lifts or accessible bathing
  • Medication management

Nesta's report estimated that formal social care for people living with obesity could cost local authorities £1 billion in 2025.



But that's not the only type of social care that puts a financial strain on society. When family members and friends step in to provide support ('informal social care'), that comes at a cost, too.


Picture of someone knocking on a door.

After all, those informal carers are spending time caring for loved ones for free. That's a very nice thing to do, but it means they're using up time when they could have been earning money or spending on leisure.


The report estimates that these informal social care arrangements could cost society £9.3 billion in 2025.


Lost productivity at work

Obesity and the health problems it can come with can affect people in their place of work. This can have a knock-on effect on the economy to the tune of an estimated £23.8 billion in 2025. Here's how.

Unemployment

People living with obesity are less likely to be employed than those at a healthy weight. One study of more than 17,000 working-age adults in England found that, compared to healthy-weight individuals, employment was:


  • 21% lower in females living with obesity
  • 8.4% lower in males living with obesity

However, it's important to note that factors that aren't always observable to the researcher, such as socioeconomic background, may influence these statistics.


Time off work (presenteeism)

This includes sick days and days off work to attend health appointments, for example.


Workers living with class III obesity (a BMI of 40+) account for more than 40% of presenteeism costs (£3.9 billion out of £9.7 billion). However, they only represent 13% of the workforce with obesity.


Reduced productivity at work

Living with obesity can also influence factors like the quality and quantity of a person's work.  For instance, if a person with obesity develops sleep apnoea, it may cause tiredness. In turn, this can make it difficult to concentrate during the working day.


So, as you can see, the cost of obesity goes further than NHS spending. It can affect people's careers and well-being, too.

SemaPen is a weight loss clinic founded by UK obesity experts. As part of Phoenix Health, we've helped people lose weight for more than 20 years.


Sources

1. House of Commons Library (2025) Research briefing: Obesity statistics. Retrieved from https://commonslibrary.parliament.uk/research-briefings/sn03336/


2. Nesta (2025) The economic and productivity costs of obesity and overweight in the UK. Retrieved from https://media.nesta.org.uk/documents/The_economic_and_productivity_costs_of_obesity_and_overweight_in_the_UK_.pdf

This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, on 31 October 2025.


  • Average 15-21% weight loss*
  • Tailored programmes built by real experts
  • Targeted support to make success feel simpler
  • Unique app with weight loss tools and lessons

Your journey starts here

Start your personalised weight loss plan in minutes.

1

Start your online consultation

2

Get approved by our clinical team

3

Begin your programme

Get started
Wondering if weight loss can cause depression? The simple answer: it depends on how you do it.
by Simon Edward • 9 October 2026
Wondering if weight loss can cause depression? The simple answer: it depends on how you do it.
Obesity is a leading cause of obstructive sleep apnoea.
by Simon Edward • 5 October 2026
Obesity is a leading cause of obstructive sleep apnoea. Does that mean weight loss injections can help? Let's look at the evidence.
Wondering where you'll notice weight loss first? Discover the early signs of fat loss
by Simon Edward • 2 October 2026
Wondering where you'll notice weight loss first? Discover the early signs of fat loss and why it's worth celebrating achievements beyond the scale.
A recent trial tested Wegovy for weight loss in children aged 6 to 11.
by Simon Edward • 30 September 2026
A recent trial tested Wegovy for weight loss in children aged 6 to 11. Does that mean younger children will soon be able to access the drug?
Retatrutide is an experimental weight loss drug that's not approved for treatment anywhere.
by Simon Edward • 28 September 2026
Retatrutide is an experimental weight loss drug that's not approved for treatment anywhere. So, why are websites offering it for sale in 2026?
Explore the fastest medically supervised weight loss options, from GLP-1 injections
by Simon Edward • 11 September 2026
Explore the fastest medically supervised weight loss options, from GLP-1 injections to total diet replacement, and learn why speed isn't everything.
Non-surgical weight loss procedures may help you lose weight without conventional surgery.
by Simon Edward • 1 September 2026
Non-surgical weight loss procedures may help you lose weight without conventional surgery. Learn about your options and which might suit you.
A new GLP-1 drug called 'avexitide' is in development, but it works very differently from Wegovy.
by Simon Edward • 31 August 2026
A new GLP-1 drug called 'avexitide' is in development, but it works very differently from Wegovy and Mounjaro. Get the facts in our guide.
Learn how medically supervised total diet replacement (TDR) programmes work
by Simon Edward • 28 August 2026
Learn how medically supervised total diet replacement (TDR) programmes work, who they're suitable for and what the evidence says.
Learn who total diet replacement programmes are designed for, how they work
by Simon Edward • 24 August 2026
Learn who total diet replacement programmes are designed for, how they work and whether they could support your weight loss goals.
More posts